Why is Ishita Drugs falling/rising?

As of 03-Jul, Ishita Drugs & Industries Ltd is currently priced at 84.00, reflecting a slight increase of 0.07 (0.08%). The stock has been gaining momentum, having risen 2.94% over the last two days, although it underperformed its sector by 0.4% today. Despite this recent uptick, the stock has a year-to-date decline of 9.12%, although it has generated a notable return of 27.62% over the past year. The company is trading at a discount compared to its peers, with an attractive valuation indicated by a Price to Book Value of 2.5. However, it faces challenges with weak long-term fundamental strength, as evidenced by a low average Return on Equity (ROE) of 8.34% and poor growth in net sales and operating profit over the past five years.
Broader market context shows that while Ishita Drugs has outperformed the broader market with a 27.62% return over the past year compared to the BSE500's 2.20%, its short-term performance has been mixed. The stock's recent gains come amid a broader market decline, as the Sensex has decreased by 0.62% over the past week. Additionally, there is a concerning trend of falling investor participation, with delivery volume dropping significantly, which may indicate a lack of confidence among investors despite the stock's recent price increase.